Steven Shak, Chief Scientific Officer at GENOMIC HEALTH INC (GHDX), sold 50,000 shares at $56.97 ($2.8M) on 2019-07-08, disclosed to the SEC on 2019-07-10.
Scheduled sale ($2.8M) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $56.97 | 20,952 | $1.2M | 42.0% |
| 2 | $57.76 | 4,048 | $234K | 8.2% |
| 3 | $56.27 | 17,200 | $968K | 34.1% |
| 4 | $57.06 | 7,800 | $445K | 15.7% |
| Total | $56.81 avg | 50,000 | $2.8M | 100% |
| Filing → |
| GHDX | SELL | 2019-08-05 | $3.6M | — | Filing → |
| GHDX | SELL | 2019-06-17 | $3.7M | — | Filing → |
| GHDX | SELL | 2019-06-13 | $5.1M | — | Filing → |